Thiruvananthapuram, Oct 16 (PTI) Researchers at the BRIC-RGCB here have received a grant of Rs 7 crore to develop an automated diagnostic device to detect early signs of cervical cancer from a blood ...

The FDA is expected to approve a new kind of blood test that may allow earlier diagnosis and less invasive, more effective ...

A revolutionary blood test designed to detect more than 50 types of cancer has failed to achieve its main goal in a trial ...

Led by the University of Queensland (UQ), the CLARITY cervical cancer study at the Royal Brisbane and Women's Hospital will investigate the potential of blood biomarkers in the screening, monitoring ...

Chief investigator Professor Andreas Obermair from UQ’s Queensland Centre for Gynaecological Cancer Research said the study ...

A controversial blood test aimed at detecting multiple cancers was backed by a U.S. Food and Drug Administration panel this week. Here's what to know.

IntroductionWhen you first visit a doctor after finding out you are pregnant, you will be asked to fill out a medical ...

The harder question is whether finding more cancers through the test actually helps people live longer. If you enjoyed this ...

A preliminary French feasibility study detected circulating tumor cells in the blood of patients during laparoscopic surgery ...

The U.S. Food and Drug Administration (FDA) endorsed a blood test designed to spot early signs of dozens of cancers despite concerns about how definitive the test’s results may be, the Associated ...

A bank of biological samples from thousands of Brazilians could help the Unified Health System (SUS), which is public and ...

A GC-MS metabolomics study of 55 cervical cancer patients has identified serum biomarkers linked to disease stage, treatment ...